Search / Trial NCT06222216

The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults

Launched by TC ERCIYES UNIVERSITY · Jan 22, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Description

Subcutaneous (SC) injection applications are the process of administering the drug to the loose connective tissue under the skin and is one of the most frequently applied parenteral drug administration methods among nursing practices. SC injections, which are frequently performed by nurses, often result in complications such as hematoma, ecchymosis and pain at the injection site. Although the field of healthcare is developing day by day, injection applications can still be painful and uncomfortable. These procedures increase the individual's stress levels before the procedure, causing them ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Able to speak and understand Turkish,
  • 2. Those between the ages of 18-65,
  • 3. Oriented to place and time,
  • 4. Having no vision or hearing problems,
  • 5. Not using psychiatric medication due to any psychiatric disease,
  • 6. Not using central nervous system medication,
  • 7. Not using narcotic analgesics,
  • 8. Having a Visual Comparison Scale pain score of zero at the time of application,
  • 9. Those who have not had SC injection in the last month,
  • 10. Low molecular weight heparin therapy is ordered (Enoxaparin Sodium 1\*4000 IU),
  • 11. Having an average pressure pain threshold of 8-16 pounds (Lb) with the Baseline Algometer device,
  • 12. Has normal platelet, INR, and aPTT values,
  • 13. Individuals who volunteer to participate in the study and sign the written voluntary consent form will be included in the research.
  • Exclusion Criteria:
  • 1. Vital signs not within the reference range,
  • 2. Those with signs of phlebitis, scar tissue, dermatitis, incision and infection in the area where the intervention will be performed,
  • 3. Having had a mastectomy,
  • 4. Patients who declare that they are addicted to alcohol and drugs will not be included in the research.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Kayseri, Talas, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0